CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.
暂无分享,去创建一个
W. Ye | P. Chu | Xiwei Wu | Shiuan Chen | A. Chow | P. Scherle | A. Li | G. Somlo | Jun Wu | S. Wang | Yang Yu | X. Ren | T. Luu | Weiying Zhou | Akihiro Tsuyada | S. Loera | Yuan-Zhong Wang | Hui Li | Y. Kuroki
[1] R. Strieter,et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. , 1989, Biochemical and biophysical research communications.
[2] T. Kadesch,et al. Notch signaling: a dance of proteins changing partners. , 2000, Experimental cell research.
[3] H. Saji,et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] H. Saji,et al. Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.
[5] M. Fitzgibbon,et al. Structure of Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Suggests a Bifunctional Switch That Couples Kinase Activation with Nuclear Export* , 2002, The Journal of Biological Chemistry.
[6] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[7] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[8] B. Winblad,et al. Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain* , 2003, Journal of Biological Chemistry.
[9] R. Weinberg,et al. Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Dontu,et al. Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.
[11] Sally E. Johnson,et al. MEKK1 Signaling through p38 Leads to Transcriptional Inactivation of E47 and Repression of Skeletal Myogenesis* , 2004, Journal of Biological Chemistry.
[12] Howard Y. Chang,et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[14] Carlos L Arteaga,et al. HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors. , 2006, Cancer cell.
[15] Guihua Sun,et al. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] C. Huff,et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma , 2007, Proceedings of the National Academy of Sciences.
[17] C. Thiele,et al. Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. , 2007, The Journal of clinical investigation.
[18] Frederick Y. Wu,et al. Convergence of p53 and Transforming Growth Factor β (TGFβ) Signaling on Activating Expression of the Tumor Suppressor Gene maspin in Mammary Epithelial Cells* , 2007, Journal of Biological Chemistry.
[19] Hua Yu,et al. Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.
[20] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[21] S. Dermime,et al. Expression of B7‐H1 in breast cancer patients is strongly associated with high proliferative Ki‐67‐expressing tumor cells , 2007, International journal of cancer.
[22] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[23] M. Lopes,et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. , 2008, Oral oncology.
[24] A. Ben-Baruch,et al. The inflammatory chemokines CCL2 and CCL5 in breast cancer. , 2008, Cancer letters.
[25] S. Blacklow,et al. Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A. , 2009, Genes & development.
[26] Y. Liu,et al. p53 regulates hematopoietic stem cell quiescence. , 2009, Cell stem cell.
[27] S. Kane,et al. Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines , 2009, Clinical Cancer Research.
[28] F. Sánchez-Jiménez,et al. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. , 2009, The international journal of biochemistry & cell biology.
[29] W. Glasgow,et al. Src-dependent STAT-3-mediated Expression of Monocyte Chemoattractant Protein-1 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Vascular Smooth Muscle Cell Migration* , 2009, The Journal of Biological Chemistry.
[30] Xin Lu,et al. Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone* , 2009, The Journal of Biological Chemistry.
[31] Pier Paolo Di Fiore,et al. The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells , 2009, Cell.
[32] O. Er,et al. Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.
[33] M. Kerin,et al. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells , 2009, International journal of cancer.
[34] A. Li,et al. UC Office of the President Recent Work Title Context-dependent bidirectional regulation of the mutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells , 2010 .
[35] A. Richmond,et al. Chemokines and chemokine receptors: new insights into cancer-related inflammation. , 2010, Trends in molecular medicine.
[36] D. Qian,et al. CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel‐induced cytotoxicity , 2010, The Prostate.
[37] Robert A. Weinberg,et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.
[38] S. Ivy,et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways , 2011, Nature Reviews Clinical Oncology.
[39] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[40] Sophia Hsin-Jung Li,et al. Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.
[41] Yang Yu,et al. Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM , 2010, Oncogene.
[42] J. A. Yunes,et al. Increased CCL2 and IL‐8 in the bone marrow microenvironment in acute lymphoblastic leukemia , 2011, Pediatric blood & cancer.
[43] A. Capobianco,et al. Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.